Literature DB >> 22895041

Ampicillin susceptibility can predict in vitro susceptibility of penicillin-resistant, ampicillin-susceptible Enterococcus faecalis Isolates to amoxicillin but not to imipenem and piperacillin.

Natália Conceição1, Cristina da Cunha Hueb Barata de Oliveira, Lucas Emanuel Pinheiro da Silva, Laís Rezende Cardoso de Souza, Adriana Gonçalves de Oliveira.   

Abstract

Our findings demonstrated that the results obtained for ampicillin may accurately predict the in vitro susceptibility to amoxicillin but not to imipenem and piperacillin among isolates of Enterococcus faecalis resistant to penicillin but susceptible to ampicillin, which have emerged recently, in contrast to penicillin- and ampicillin-susceptible isolates.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22895041      PMCID： PMC3486203          DOI： 10.1128/JCM.01246-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  7 in total

1.  Gentamicin-resistant Enterococcus faecalis sequence type 6 with reduced penicillin susceptibility: diagnostic and therapeutic implications.

Authors:  Luca Guardabassi; Jesper Larsen; Robert Skov; Henrik C Schønheyder
Journal:  J Clin Microbiol       Date:  2010-08-11       Impact factor: 5.948

2.  Spread of an unusual penicillin- and imipenem-resistant but ampicillin-susceptible phenotype among Enterococcus faecalis clinical isolates.

Authors:  Evgenia Metzidie; Evangelos N Manolis; Spyros Pournaras; Danai Sofianou; Athanassios Tsakris
Journal:  J Antimicrob Chemother       Date:  2005-11-24       Impact factor: 5.790

3.  Prediction of piperacillin-tazobactam susceptibility among Enterobacteriaceae, Pseudomonas aeruginosa, and other bacteria using ticarcillin-clavulanic acid, ceftazidime, and other broad-spectrum antimicrobial in vitro test results.

Authors:  R N Jones; L D Sutton; H F Cantrell; R B Lankford
Journal:  Diagn Microbiol Infect Dis       Date:  1994-11       Impact factor: 2.803

4.  Comparative evaluation of penicillin, ampicillin, and imipenem MICs and susceptibility breakpoints for vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.

Authors:  M P Weinstein
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

5.  Trends in antimicrobial resistance among clinical isolates of enterococci in a Brazilian tertiary hospital: a 4-year study.

Authors:  Natália Conceição; Cristina da Cunha Hueb Barata de Oliveira; Paulo Roberto da Silva; Bárbara Godoi Melo Avila; Adriana Gonçalves de Oliveira
Journal:  Rev Soc Bras Med Trop       Date:  2011-04-01       Impact factor: 1.581

Review 6.  Penicillin-binding proteins and beta-lactam resistance.

Authors:  André Zapun; Carlos Contreras-Martel; Thierry Vernet
Journal:  FEMS Microbiol Rev       Date:  2008-01-29       Impact factor: 16.408

7.  Multicenter evaluation of use of penicillin and ampicillin as surrogates for in vitro testing of susceptibility of enterococci to imipenem.

Authors:  Melvin P Weinstein; Stanley Mirrett; Saman Kannangara; Jan Monahan; Lizzie J Harrell; Alan C Wilson; L Barth Reller
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948
  7 in total
  6 in total

1.  Clinical epidemiology of vancomycin-resistant Enterococcus gallinarum and Enterococcus casseliflavus bloodstream infections.

Authors:  Nicholas S Britt; Emily M Potter
Journal:  J Glob Antimicrob Resist       Date:  2015-12-21       Impact factor: 4.035

2.  Outcomes of Patients with Bloodstream Infections Caused by Ampicillin-Susceptible but Penicillin-Resistant Enterococcus faecalis: Caution in Interpreting the Results.

Authors:  Nicolo L Cabrera; Alexandre E Malek; Samuel L Aitken; Cesar A Arias
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

3.  Impact of different antimicrobial therapies on clinical and fiscal outcomes of patients with bacteremia due to vancomycin-resistant enterococci.

Authors:  Kayoko Hayakawa; Emily T Martin; Uma Mahesh Gudur; Dror Marchaim; Dalia Dalle; Khaled Alshabani; Kalyan Srinivas Muppavarapu; Fnu Jaydev; Pradeep Bathina; Pranathi Rao Sundaragiri; Shashi Dhar Rajuri; Jaikumar Khatri; Jason M Pogue; Paul R Lephart; Michael J Rybak; Keith S Kaye
Journal:  Antimicrob Agents Chemother       Date:  2014-05-05       Impact factor: 5.191

Review 4.  Antimicrobial Susceptibility Testing for Enterococci.

Authors:  Ayesha Khan; William R Miller; Dierdre Axell-House; Jose M Munita; Cesar A Arias
Journal:  J Clin Microbiol       Date:  2022-06-13       Impact factor: 11.677

5.  Antimicrobial Effects of L-Chg10-Teixobactin against Enterococcus faecalis In Vitro.

Authors:  Alaa Jarkhi; Angeline Hui Cheng Lee; Zhenquan Sun; Mingxin Hu; Prasanna Neelakantan; Xuechen Li; Chengfei Zhang
Journal:  Microorganisms       Date:  2022-05-26

6.  Beta-lactams susceptibility testing of penicillin-resistant, ampicillin-susceptible Enterococcus faecalis isolates: a comparative assessment of Etest and disk diffusion methods against broth dilution.

Authors:  Natália Conceição; Wellington Francisco Rodrigues; Kessys Lorrânya Peralta de Oliveira; Lucas Emanuel Pinheiro da Silva; Laís Rezende Cardoso de Souza; Cristina da de Cunha Hueb Barata Oliveira; Adriana Gonçalves de Oliveira
Journal:  Ann Clin Microbiol Antimicrob       Date:  2020-09-17       Impact factor: 3.944
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.